Shabaana A. Khader

University of Chicago

NIH Rank #1120
  • Program Leader
  • R01 Holder
  • Top 10% Funded
  • Early Career
  • Diverse Portfolio

NIH Funding · FY2024

Total Funding
$5M
Fiscal year 2024
Grants Awarded
6
Active NIH grants
National Rank
#1,120
Among 57,894 PIs
First NIH Award
2024
Year of first funding

Funding & rank history

NIH funding totals and national rank by fiscal year.

Single fiscal year on record (FY2024): $5M across 6 grants · National rank #1120.

Top grants by award amount

Shabaana A. Khader's NIH grant portfolio, ranked by award amount.

  • 5R01AI111914-09R01
    Role of Inducible Bronchus Associated Lymphoid Tissue in Latent Tuberculosis
    $1.4M
    award amount
  • 1R01AI184623-01R01
    Mechanisms of efficient control of Mycobacterium tuberculosis in the lungs prior to granuloma
    $1.1M
    award amount
  • 5R01AI155024-05R01
    Understanding the functional role of Myeloid Derived Suppressor cells in tuberculosis
    $881.9K
    award amount
  • 5U01AI160406-04U01
    Targeting trained immunity and Th1/Th17 axis with combination adjuvants
    $600K
    award amount
  • 5R01HL105427-13R01
    Role of IL-17 in Protective Vaccine-induced Immune Responses Against Tuberculosis
    $570.4K
    award amount
  • 5R61AI169071-03R61
    Development of a novel adjuvanted Th1- and Th17-inducing subunit TB Vaccine
    $472.3K
    award amount

Affiliations

Institutions that have administered grants for Shabaana A. Khader.

Career milestones

Key NIH funding milestones over time.

  1. 2024
    First NIH Award
    University of Chicago
  2. 2024
    $500K Cumulative Funding
  3. 2024
    $1M Cumulative Funding
  4. 2024
    $2M Cumulative Funding
  5. 2024
    Entered Top 50% Nationally
    Ranked #1120
  6. 2024
    Entered Top 25% Nationally
    Ranked #1120
  7. 2024
    Entered Top 10% Nationally
    Ranked #1120
  8. 2024
    Multi-Institutional Research
    Awards at 2 institutions